ImpediMed Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.05 |
Market Cap |
$48.11 M |
Shares Outstanding |
378.91 M |
Public Float |
- |
ImpediMed Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.06 |
Market Cap |
AUD68.36 M |
Shares Outstanding |
379.8 M |
Public Float |
334.67 M |
Address |
50 Parker Court Pinkenba Queensland (QLD) 4008 Australia |
Employees | - |
Website | http://www.impedimed.com |
Updated | 07/08/2019 |
ImpediMed Ltd. engages in the development and distribution of medical devices using bioimpedance spectroscopy technologies for use in the non-invasive clinical assessment and monitoring of human disorders and diseases. It operates through the Medical and Test and Measurement segments. The Medical segment supplies non-invasive medical devices to two under-served markets: aiding in the subclinical assessment of individuals at risk of secondary lymphoedema; and the monitoring of body composition and hydration. |